Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.

Yoshizaki T, Horikawa T, Qing-Chun R, Wakisaka N, Takeshita H, Sheen TS, Lee SY, Sato H, Furukawa M.

Clin Cancer Res. 2001 Jul;7(7):1946-51.

3.

Induction of receptor for advanced glycation end products by EBV latent membrane protein 1 and its correlation with angiogenesis and cervical lymph node metastasis in nasopharyngeal carcinoma.

Tsuji A, Wakisaka N, Kondo S, Murono S, Furukawa M, Yoshizaki T.

Clin Cancer Res. 2008 Sep 1;14(17):5368-75. doi: 10.1158/1078-0432.CCR-08-0198.

4.

Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.

Ho CH, Chen CL, Li WY, Chen CJ.

Carcinogenesis. 2009 Aug;30(8):1443-51. doi: 10.1093/carcin/bgp135. Epub 2009 May 29.

PMID:
19483191
6.
7.

EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX.

Grimm T, Schneider S, Naschberger E, Huber J, Guenzi E, Kieser A, Reitmeir P, Schulz TF, Morris CA, St├╝rzl M.

Blood. 2005 Apr 15;105(8):3263-9. Epub 2004 Dec 21.

8.

Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1.

Okudaira T, Yamamoto K, Kawakami H, Uchihara JN, Tomita M, Masuda M, Matsuda T, Sairenji T, Iha H, Jeang KT, Matsuyama T, Takasu N, Mori N.

Br J Haematol. 2006 Feb;132(3):293-302. Retraction in: Br J Haematol. 2011 Mar;152(6):787.

PMID:
16409294
9.

Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro.

O'Neil JD, Owen TJ, Wood VH, Date KL, Valentine R, Chukwuma MB, Arrand JR, Dawson CW, Young LS.

J Gen Virol. 2008 Nov;89(Pt 11):2833-42. doi: 10.1099/vir.0.2008/003392-0.

PMID:
18931081
10.
11.

Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.

Hsu M, Wu SY, Chang SS, Su IJ, Tsai CH, Lai SJ, Shiau AL, Takada K, Chang Y.

J Virol. 2008 Apr;82(7):3679-88. doi: 10.1128/JVI.02301-07. Epub 2008 Jan 30.

13.

Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.

Tao YG, Tan YN, Liu YP, Song X, Zeng L, Gu HH, Tang M, Li W, Yi W, Cao Y.

Cell Signal. 2004 Jul;16(7):781-90.

PMID:
15115657
14.

Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.

Krauer KG, Belzer DK, Liaskou D, Buck M, Cross S, Honjo T, Sculley T.

Virology. 1998 Dec 20;252(2):418-30.

15.

Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells.

Xu L, Xie K, Mukaida N, Matsushima K, Fidler IJ.

Cancer Res. 1999 Nov 15;59(22):5822-9.

16.

Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients.

Ben Nasr H, Chahed K, Remadi S, Zakhama A, Chouchane L.

Arch Med Res. 2009 Apr;40(3):196-203. doi: 10.1016/j.arcmed.2009.02.007. Epub 2009 Apr 8.

PMID:
19427971
17.
18.

Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.

Yoshizaki T, Endo K, Ren Q, Wakisaka N, Murono S, Kondo S, Sato H, Furukawa M.

Auris Nasus Larynx. 2007 Mar;34(1):73-8. Epub 2006 Nov 28.

PMID:
17129696
19.

CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, AND CBF1.

Mann J, Oakley F, Johnson PW, Mann DA.

J Biol Chem. 2002 May 10;277(19):17125-38. Epub 2002 Mar 8.

20.

[Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].

You S, Yao K, Cao Y.

Zhonghua Zhong Liu Za Zhi. 1996 Jan;18(1):23-6. Chinese.

PMID:
8732106

Supplemental Content

Support Center